The Potential Role Of Monocyte Chemoattractant Protein-1 For Major Depressive Disorder (MDD)
Research Summary | June 27, 2016
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
Key Messages Evidence of an association between the immune system and the pathophysiology of major depressive disorder (MDD) has been reported. This review provides an overview of evidence supporting the role of the chemokine monocyte chemoattractant protein-1 (MCP-1) in MDD development. The author concluded that MCP-1 may play a role in MDD development based on…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.